Cobra Bio-manufacturing enters malaria vaccine JV with US Navy agency


LONDON (AFX) - Cobra Bio-Manufacturing PLC said it has signed a research and development agreement with the Naval Medical Research Center of the US Navy to construct and test a vaccine against malaria.

The venture will use Cobra's proprietary ORT-VAC oral vaccine delivery technology.

Cobra said it is already in the course of evaluating the ORT-VAC platform in the development of a vaccine against anthrax and plague with the UK Defence Science and Technology Laboratory at Porton Down, and similar technology will be used for this collaboration with the US Navy.

Financial terms were not disclosed.